Neuronetics, Inc — Revenue by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/ba5b969e-989a-49e3-ba2f-2f70c43786e5/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $149.2M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-029004 |
| FY 2024 | $74.9M | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-003833 |
| FY 2023 | $71.3M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-002772 |
| FY 2022 | $65.2M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-003044 |
| FY 2021 | $55.3M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-003069 |
| FY 2020 | $49.2M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-010320 |
| FY 2019 | $62.7M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-008464 |
| FY 2018 | $52.8M | 2018-01-01 – 2018-12-31 | evidence 0001564590-20-008464 |
| FY 2017 | $40.4M | 2017-01-01 – 2017-12-31 | evidence 0001564590-20-008464 |
| FY 2016 | $34.2M | 2016-01-01 – 2016-12-31 | evidence 0001564590-19-006276 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Neuronetics, Inc — all facts · Net Income · Operating Income